Daniel Bradbury insider trades
Open-market stock purchases and sales by Daniel Bradbury, Director at Vivani Medical, Inc, from SEC Form 4 filings since Mar 1, 2011.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -22%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 24, 2026 | VANI Vivani Medical, Inc | Bought (not open market) | $44.5K |
| May 28, 2026 | EQ Equillium, Inc | Bought (not open market) | — |
| May 28, 2026 | CSTL Castle Biosciences Inc | Bought (not open market) | — |
| May 22, 2026 | CSTL Castle Biosciences Inc | Bought (not open market) | — |
| Jan 1, 2026 | VANI Vivani Medical, Inc | Bought (not open market) | $58.1K |
Companies traded
- VANI Vivani Medical, Inc: other filings, last Jun 24, 2026
- EQ Equillium, Inc: other filings, last May 28, 2026
- CSTL Castle Biosciences Inc: 398 sales, last May 28, 2026
- ICPT Intercept Pharmaceuticals, Inc: 1 buy, last Nov 8, 2023
- NUVB Nuvation Bio Inc: other filings, last Feb 10, 2021
- GERN Geron Corp: 1 buy, last Mar 29, 2019
- CORT Corcept Therapeutics Inc: 4 buys, 12 sales, last Feb 7, 2019
- ILMN Illumina Inc: 133 sales, last May 25, 2017
- BMR BioMed Realty Trust Inc: other filings, last Jan 27, 2016
- AMLN Amylin Pharmaceuticals Inc: 1 sale, last Aug 8, 2012